- Report
- August 2023
- 51 Pages
China
From €531EUR$600USD£459GBP
- Report
- August 2023
- 51 Pages
France
From €531EUR$600USD£459GBP
- Report
- August 2023
- 51 Pages
Brazil
From €531EUR$600USD£459GBP
- Report
- August 2023
- 1300 Pages
Global
From €7875EUR$8,900USD£6,810GBP
- Report
- October 2022
- 65 Pages
Global
From €3495EUR$3,950USD£3,022GBP
- Report
- August 2024
- 116 Pages
Global
From €3982EUR$4,500USD£3,443GBP
- Report
- January 2024
- 130 Pages
Global
From €3982EUR$4,500USD£3,443GBP
- Report
- February 2024
- 132 Pages
Global
From €841EUR$950USD£727GBP
- Book
- July 2020
- 580 Pages
- Report
- November 2021
- 802 Pages
Global
From €4424EUR$5,000USD£3,826GBP
- Report
- November 2021
- 1184 Pages
Global
From €5309EUR$6,000USD£4,591GBP
- Book
- December 2022
- 464 Pages
- Book
- December 2019
- 400 Pages
- Book
- November 2019
- 440 Pages
- Book
- April 2018
- 200 Pages
- Book
- July 2025
- 368 Pages

Genome Editing is a technology used to make precise changes to the DNA of living organisms. It is used in a variety of applications, including gene therapy, crop engineering, and basic research. Genome Editing is a rapidly growing field within the genomics industry, as it allows for the manipulation of genetic material with unprecedented accuracy and speed.
Genome Editing is typically done using a variety of tools, such as CRISPR-Cas9, TALENs, and ZFNs. These tools allow for the insertion, deletion, or modification of specific DNA sequences. This technology has enabled researchers to make targeted changes to the genome of living organisms, allowing for the development of new treatments and therapies.
The Genome Editing market is expected to continue to grow in the coming years, as the technology is increasingly used in a variety of applications. Companies in the market include Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences, and Sangamo Therapeutics. Show Less Read more